+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

Immuno-Oncology Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno-Oncology Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 197 Pages
  • Global
From
Oncology Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oncology Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
From
VEGF Inhibitors for Cancer Market - Global Forecast 2025-2030 - Product Thumbnail Image

VEGF Inhibitors for Cancer Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
From
CTLA4 Inhibitors Market Report 2026 - Product Thumbnail Image

CTLA4 Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Intratumoral Cancer Therapies Market Report 2026 - Product Thumbnail Image

Intratumoral Cancer Therapies Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
MSI-H and dMMR Market Report 2026 - Product Thumbnail Image

MSI-H and dMMR Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Head and Neck Cancer Therapeutics Market Report 2026 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Checkpoint Inhibitor Refractory Cancer Market Report 2026 - Product Thumbnail Image

Checkpoint Inhibitor Refractory Cancer Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Liver Cancer Therapeutics Market Report 2026 - Product Thumbnail Image

Liver Cancer Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Malignant Mesothelioma Market Report 2026 - Product Thumbnail Image

Malignant Mesothelioma Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
PD-1 Resistant Head and Neck Cancer Market Report 2026 - Product Thumbnail Image

PD-1 Resistant Head and Neck Cancer Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cancer Supportive Care Drugs Market Report 2026 - Product Thumbnail Image

Cancer Supportive Care Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Hepatocellular Carcinoma Drugs Market Report 2026 - Product Thumbnail Image

Hepatocellular Carcinoma Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Oncolytic Virus Therapy Market Report 2026 - Product Thumbnail Image

Oncolytic Virus Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more